MedTrace Logo

Intervention to Reduce Infectious Complications of Peritoneal Dialysis

NCT06536673 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-09-19

No results posted yet for this study

Summary

Peritonitis is a common and serious complication of peritoneal dialysis (PD) and is one of the main causes of peritoneal dialysis technique failure and long-term hemodialysis conversion.

Conditions

  • Peritoneal Infection

Interventions

BEHAVIORAL

Intervention to reduce infectious complications of peritoneal dialysis

* Before catheter placement: The nurse and doctor provide the patient and/or caregiver with a PD simulation. * Initial training: from the placement of the catheter to the beginning of the technique at home, approximately 4 weeks, 6 and 7 sessions, duration 1-2 hours per session. Individualized learning taking into account learning abilities and education. It includes the explanation of the PD and the display of informational pictograms/capsules. * Step-by-step teaching: peritoneal exchange, peritoneal orifice care, administration of intraperitoneal medication, recording of constants, detection of complications and risk behaviors. * Nutritional education and water intake. * Administration of the Objective Structured Assessment (OSA) checklist. * Retraining: between the 1st and 3rd month of the start, after an episode of peritonitis and/or hospitalization, risk behaviors, functional/cognitive impairment, passivity/demotivation behaviors, and regularly once the year.

BEHAVIORAL

Data collection from the patient's clinical history

Data collection from the patient's clinical history because this new standardized educational intervention was not used.

Sponsors & Collaborators

  • Universitat de Lleida

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-15
Primary Completion
2025-02-01
Completion
2025-09-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06536673 on ClinicalTrials.gov